The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity
Clinical trial NCT05897008 · COMPLETED
Trial details
- NCT number
- NCT05897008
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2022-06-27
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.